Suppr超能文献

有纹理组织扩张器的患者中乳房植入物相关间变大细胞淋巴瘤的风险。

Risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Patients with Textured Tissue Expanders.

机构信息

From the Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center.

出版信息

Plast Reconstr Surg. 2023 Jul 1;152(1):32-37. doi: 10.1097/PRS.0000000000010195. Epub 2023 Jun 29.

Abstract

BACKGROUND

The association between textured implants and breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is well established, but the risk of BIA-ALCL in patients with transient exposure to a textured tissue expander (TE) is not as well documented. The aim of this study was to assess the incidence and risk of BIA-ALCL in patients with temporary exposure to a textured TE with subsequent smooth implant placement.

METHODS

This single-institution retrospective cohort study included all female patients who underwent two-stage breast reconstruction with placement of a textured TE from 1995 to 2016 with subsequent exchange to a smooth permanent implant. Primary outcome of interest was development of BIA-ALCL. Patients with exposure to textured implants were excluded. Follow-up was determined by last documented visit. The authors calculated summary statistics for exposure time and follow-up intervals.

RESULTS

Overall, 3310 patients had temporary exposure to a textured TE with exchange to a smooth implant, totaling 5201 textured TEs. Average textured TE exposure time was 6.7 months (median, 5.8 months). Average follow-up was 6.8 years (median, 6.3 years), ranging from 3.7 months to 18 years. No cases of BIA-ALCL were identified.

CONCLUSIONS

As no cases of BIA-ALCL were identified, the risk of BIA-ALCL with short exposure to textured TEs is likely lower than the risk from exposure to permanent textured implants. Although longer follow-up is needed, these results can help counsel patients with previous exposure to textured TEs who are concerned about their risk of BIA-ALCL and can contribute to discussions on potential continued utility of textured TEs.

CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, IV.

摘要

背景

已明确证实,有纹理植入物与乳腺癌相关间变性大细胞淋巴瘤(BIA-ALCL)之间存在关联,但接受过纹理组织扩张器(TE)短暂暴露的患者发生 BIA-ALCL 的风险尚未得到充分记录。本研究旨在评估接受纹理 TE 短暂暴露后继而植入光滑假体的患者中 BIA-ALCL 的发生率和风险。

方法

这是一项单机构回顾性队列研究,纳入了 1995 年至 2016 年间接受过两阶段乳房重建并置入纹理 TE 且随后更换为光滑永久假体的所有女性患者。主要观察终点为 BIA-ALCL 的发生。排除有纹理植入物暴露史的患者。通过最后一次记录的就诊情况确定随访情况。作者计算了暴露时间和随访间隔的汇总统计数据。

结果

共有 3310 例患者接受了纹理 TE 的短暂暴露,继而更换为光滑假体,共使用了 5201 个纹理 TE。平均纹理 TE 暴露时间为 6.7 个月(中位数,5.8 个月)。平均随访时间为 6.8 年(中位数,6.3 年),随访时间范围为 3.7 个月至 18 年。未发现 BIA-ALCL 病例。

结论

由于未发现 BIA-ALCL 病例,因此纹理 TE 短期暴露的 BIA-ALCL 风险可能低于永久性纹理植入物暴露的风险。尽管需要更长时间的随访,但这些结果可以帮助曾接受过纹理 TE 暴露且担心自身 BIA-ALCL 风险的患者提供咨询,并有助于讨论纹理 TE 的潜在继续使用。

临床问题/证据水平:风险,IV 级。

相似文献

5
Current Risk Estimate of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Textured Breast Implants.有纹理假体的乳房植入物相关间变性大细胞淋巴瘤的当前风险评估。
Plast Reconstr Surg. 2019 Mar;143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):30S-40S. doi: 10.1097/PRS.0000000000005567.

本文引用的文献

8
Acellular Dermal Matrix Reduces Myofibroblast Presence in the Breast Capsule.脱细胞真皮基质可减少乳腺包膜中肌成纤维细胞的存在。
Plast Reconstr Surg Glob Open. 2019 May 17;7(5):e2213. doi: 10.1097/GOX.0000000000002213. eCollection 2019 May.
10
Current Risk Estimate of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Textured Breast Implants.有纹理假体的乳房植入物相关间变性大细胞淋巴瘤的当前风险评估。
Plast Reconstr Surg. 2019 Mar;143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):30S-40S. doi: 10.1097/PRS.0000000000005567.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验